The report explains Takeda's initiatives for sustainable value creation through a structure based on the principles of the United Nations Global Compact (GC), mainly by presenting non-financial information such as CSR activities. The report uses a holistic approach to not only create but also sustain corporate value. The report highlights Takeda's commitment to ""putting the patient at the center"" as well as promoting a sustainable society through the company's CSR activities, including the company's ""Access to Medicines"" strategy, the company's ""Global CSR Programs"" which are decided on by employee votes, and the company's environmental protection initiatives such as ""Safe Takeda.""
Issuing Company Takeda Pharmaceutical Co., Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 5.82 MB
No. of Pages 86 pages
Reporting periodApril 1, 2016 to March 31, 2017
Report EditionUnknown
Assurance Provider KPMG AZSA Sustainability Co. Ltd.
Reporting Standards IIRC; UNGC; GRI
Materiality Assessmenttrue